We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > RACA

News List

POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company firstwordpharma
July 01, 2021
POINT Biopharma Inc. ("POINT") today announced the completion of its business combination with Therapeutics Acquisition Corp., d/b/a Research Alliance Corp.
Research Alliance Corp. I Announces Effectiveness of Registration Statement for Proposed Business Combination with POINT firstwordpharma
June 10, 2021
Therapeutics Acquisition Corp, d/b/a Research Alliance Corp. I, a Delaware corporation ("the Company") (Nasdaq: RACA) announced today that its registration statement on Form S-4 (File Number 333-254600) (as amended, the "Registration Statement"